Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 21;11(9):e053066.
doi: 10.1136/bmjopen-2021-053066.

Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up

Noor E Simons  1 , Emilie V J van Limburg Stirum  2 , Aleid G van Wassenaer-Leemhuis  3 , Martijn J J Finken  4 , Cornelieke S H Aarnoudse-Moens  3 , Jaap Oosterlaan  5 , Anneloes van Baar  6 , Tessa J Roseboom  2   7 , Arianne C Lim  8 , Madelon van Wely  2 , Marjon A de Boer  9 , Rebecca C Painter  2 , Eva Pajkrt  2 , Martijn A Oudijk  2 , Janneke van T Hooft  2 ; AMPHIA study group
Collaborators, Affiliations

Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up

Noor E Simons et al. BMJ Open. .

Abstract

Introduction: Preterm birth is one of the main problems in obstetrics, and the most important cause of neonatal mortality, morbidity and neurodevelopmental impairment. Multiple gestation is an important risk factor for preterm birth, with up to 50% delivering before 37 weeks. Progesterone has a role in maintaining pregnancy and is frequently prescribed to prevent (recurrent) preterm birth and improve pregnancy outcomes in high-risk patients. However, little is known about its long-term effects in multiple gestations. The objective of this follow-up study is to assess long-term benefits and harms of prenatal exposure to progesterone treatment in multiple gestations on child development.

Methods and analysis: This is a follow-up study of a multicentre, double-blind, placebo-controlled randomised trial (AMPHIA trial, ISRCTN40512715). Between 2006 and 2009 women with a multiple gestation were randomised at 16-20 weeks of gestation to weekly injections 250 mg 17α-hydroxyprogesterone caproate or placebo, until 36 weeks of gestation or delivery. The current long-term follow-up will assess all children (n=1355) born to mothers who participated in the AMPHIA trial, at 11-14 years of age, with internationally validated questionnaires, completed by themselves, their parents and their teachers.

Main outcomes are child cognition and behaviour: Additional outcomes are death (perinatal and up to age 14), gender identity, educational performance and health-related problems. We will use intention-to-treat analyses comparing experimental and placebo group. To adjust for the correlation between twins, general linear mixed-effects models will be used.

Ethics and dissemination: Amsterdam UMC MEC provided a waiver for the Medical Research Involving Human Subjects Act (W20_234#20.268). Results will be disseminated through peer-reviewed journals and summaries shared with stakeholders, patients and participants. This protocol is published before analysis of the results.

Trial registration number: NL8933.

Keywords: developmental neurology & neurodisability; fetal medicine; maternal medicine; perinatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

References

    1. Goldenberg RL, Culhane JF, Iams JD, et al. . Preterm birth 1: epidemiology and causes of preterm birth. Obstetric Anesthesia 2009;29:6–7. 10.1097/01.aoa.0000344666.82463.8d - DOI
    1. Allotey J, Zamora J, Cheong-See F, et al. . Cognitive, motor, behavioural and academic performances of children born preterm: a meta-analysis and systematic review involving 64 061 children. BJOG 2018;125:16–25. 10.1111/1471-0528.14832 - DOI - PubMed
    1. Aarnoudse-Moens CSH, Weisglas-Kuperus N, van Goudoever JB, et al. . Meta-nalysis of neurobehavioral outcomes in very preterm and/or very low birth weight children. Pediatrics 2009;124:717–28. 10.1542/peds.2008-2816 - DOI - PubMed
    1. Burnett AC, Anderson PJ, Cheong J, et al. . Prevalence of psychiatric diagnoses in preterm and full-term children, adolescents and young adults: a meta-analysis. Psychol Med 2011;41:2463–74. 10.1017/S003329171100081X - DOI - PubMed
    1. Fitzallen GC, Sagar YK, Taylor HG, et al. . Anxiety and depressive disorders in children born preterm: a meta-analysis. J Dev Behav Pediatr 2021;42:154–62. 10.1097/DBP.0000000000000898 - DOI - PubMed

Publication types

LinkOut - more resources